Oxidative Stress Induced by Fluoroquinolones on Treatment for Complicated Urinary Tract Infections in Indian Patients
نویسندگان
چکیده
The aim of the study is to examine the oxidative stress in patients on fluoroquinolones (ciprofloxacin, levofloxacin, gatifloxacin) therapy for complicated urinary tract infections and to correlate with plasma concentrations at different time intervals. Superoxide dismutase (SOD), glutathione, plasma antioxidant status and lipid peroxides were evaluated in 52 patients on different dosage regimens up to 5 days. There is significant and gradual elevation of lipid peroxide levels in patients on ciprofloxacin (3.6 ± 0.34 nmol/ml to 6.2 ± 0.94 nmol/ml) and levofloxacin (3.5 ± 0.84 nmol/ml to 5.1 ± 0.28 nmol/ml) dosage regimen but not with gatifloxacin (3.5 ± 0.84 nmol/ml to 3.74 ± 0.17 nmol.ml). There was substantial depletion in both SOD and glutathione levels particularly with ciprofloxacin. On the 5(th) day of treatment, plasma antioxidant status decreased by 77.6% %, 50.5%, 7.56% for ciprofloxacin, levofloxacin and gatifloxacin respectively. In conclusion ciprofloxacin and levofloxacin induce more reactive oxygen species that lead to cell damage than gatifloxacin irrespective of their concentrations in patient population.
منابع مشابه
Detection of Efflux Pumps Genes in Fluoroquinolones Resistant and Sensitive strains of Escherichia coli isolated from Patients with Urinary Tract Infection in Qom
Abstract Background and Objectives: Efflux pumps are one of the main mechanisms for antibiotic resistance in Escherichia coli strains. The aim of this study was to investigate the relationship between 5 different efflux pump genes; acrA, acrB, emrA, emrB and mdtk and fluoroquinolone resistance in E.coli Isolated from patients with urinary tract infections in Qom. Methods: In this descriptive cr...
متن کاملA Review of Levofloxacin for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Introduction Urinary tract infections (UTIs) are one of the most frequently occurring bacterial infections, accounting for over 7 million office visits and approximately 15% of community-prescribed antibiotics in the United States alone (1, 2). While the majority of these infections are uncomplicated, patients with complicated urinary tract infections (cUTIs) are, by definition, at greater risk...
متن کاملOutcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
BACKGROUND Fluoroquinolones are a guideline-recommended therapy for complicated urinary tract infections, including pyelonephritis. Elevated drug concentrations of fluoroquinolones in the urine and therapy with high-dose levofloxacin are believed to overcome resistance and effectively treat infections caused by resistant bacteria. The ASPECT-cUTI phase 3 clinical trial (ClinicalTrials.gov, NCT0...
متن کاملLevofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
Levofloxacin is a widely used fluoroquinolone approved for the treatment of complicated urinary tract infections and acute pyelonephritis. A comprehensive review of the medical literature identified five publications evaluating levofloxacin for the treatment of either complicated urinary tract infections or acute pyelonephritis. All trials, although variable in their inclusion criteria and levo...
متن کاملEvaluation of the effect of IDR-1018 antimicrobial peptide and chitosan nanoparticles on imipenem susceptible and resistant Pseudomonas aeruginosa isolated from patients with urinary tract infections from ICU
Background and aim: Excessive use of antibiotics has significantly increased resistance to common antibiotics in the treatment of urinary tract infections. In the present study, antimicrobial efficacy of chitosan nanoparticles and peptide IDR-1018 was evaluated against P. aeruginosa isolates. Methods: In the present study, 20 resistant and 20 sensitive P. aeruginosa isolates to imipenem were ...
متن کامل